ACTSI
Atlanta Clinical & Translational Science Institute
Emory Morehouse School of MedicineGeorgia Tech

Funded by: NIH | NCRR | CTSA

Rotating Image

Dr. Raison in the News

2010-2011
2011

Investigator Spotlight: Dr. Charles Raison

Charles L. Raison, MD 
Associate Professor
Department of Psychiatry
Emory University School of Medicine

Research Focus 

 An evaluation of the efficacy of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant major depression: Mechanisms and mediators - NIMH

Mechanisms of Mediatation - ARRA

Compassion and Attention Longitudinal Meditation Study - NCCAM

Phenomenology and Pathophysiology of Interferon-alpha Induced Behavioral Change - NIMH

Pathophysiologic Mechanisms of Chronic Fatigue Syndrome (CFS): Neuroendocrinology and Genomics (co-PI with Andrew Miller, MD) - CDC

Stress and Chronic Fatigue Syndrome: A Psychobiological Study in a Population-Based Sample (co-PI with Andrew Miller, MD) - CDC

ACTSI Support

Protocol support - CIN

Biomedical Informatics support - BIP

Biostatistics support - BERD

ACTSI-Supported Studies 

Compassion Meditation as a Strategy for Reducing Depressive Symptoms and Physiological Stress in Freshman College Students

Phenotyping Immune-based Depression

An evaluation of the efficacy of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant major depression

The Compassion and Attention Longitudinal Meditation (CALM) Study